FONAR (FONR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
30 Dec, 2025Executive summary
Entered into a definitive merger agreement for a take-private sale to an acquisition group led by the CEO and other executives, with a per-share cash consideration of $19.00 for common and Class B stock, $6.34 for Class C, and $10.50 for Class A preferred stock.
The transaction represents a 31.5% premium to the last trading day before announcement and is expected to close in the third fiscal quarter of 2026, subject to customary closing conditions and shareholder approval.
Financing is secured through a $35 million bank facility, $10 million in additional debt, and $45 million in equity from the acquisition group and third parties; the deal is not contingent on financing.
Upon completion, shares will be delisted from Nasdaq and deregistered under the Exchange Act.
Voting matters and shareholder proposals
Shareholders will vote on the merger at a special meeting, requiring approval by a majority of all shares and a majority of disinterested shares.
Voting agreements have been executed with members of the acquisition group, aggregating 6,622,872 votes, but these are excluded from the disinterested shareholder approval calculation.
The company may consider superior proposals under certain conditions, with a termination fee of $450,000 payable if the agreement is terminated for a superior offer.
Board of directors and corporate governance
A special committee of independent directors unanimously recommended the merger, and the board (excluding interested directors) unanimously approved it.
Directors and officers of the surviving corporation will be those of the merger sub immediately prior to closing.
The certificate of incorporation will be amended and restated at closing.
Latest events from FONAR
- Independent directors secured a cash buyout at a premium, pending key stockholder approvals.FONR
Proxy Filing26 Feb 2026 - Six-month net income fell 16%, but quarterly net income rose 15%; merger at $19/share signed.FONR
Q2 202617 Feb 2026 - Definitive merger agreement signed for $19.00/share; quarterly net income up 15% year-over-year.FONR
Proxy Filing17 Feb 2026 - Annual meeting to vote on directors, executive pay, and auditors amid continued growth and strong liquidity.FONR
Proxy Filing2 Dec 2025 - Revenue up 4% to $26M, but net income down 33% as costs rise and uncertainty persists.FONR
Q1 202614 Nov 2025 - Revenue up 1%, net income down 24%, with record scan volumes and expansion plans.FONR
Q4 202525 Sep 2025 - Net income rose 16% on record scan volumes and continued expansion of MRI centers.FONR
Q4 202413 Jun 2025 - MRI scan volume rose, but revenue and net income declined amid higher costs and disruptions.FONR
Q1 202513 Jun 2025 - Q3 net income up 24%, but nine-month profit fell as costs and scan volumes rose.FONR
Q3 20256 Jun 2025